Trinean NV, a Gentbrugge, Belgium-based instrumentation company, has secured €2.7m of growth financing.
The round was led by the current investors Vesalius Biocapital, Capital-E, Baekeland II Fund and Fidimec.
The company intends to use the funding to further accelerate the development of its analytical platform, as well as expand its sales, marketing and distribution channels.
Founded in 2006 as a spin-out of the University of Ghent, Belgium, Trinean provides a platform comprised of highly accurate spectrophotometry instruments, state-of-the-art analytical software, proprietary disposables for standardized micro-volume sample analysis and flexible lab-automation tools.
The company also appointed Philippe Stas as new CEO, succeeding Dr. Marc Zabeau, who remains a member of the board of directors. Prior to joining Trinean, Philippe Stas was CEO of Algonomics NV, a Belgium based biotech service provider.
FinSMEs
30/04/2012